Another study characterized the heterogeneity of PMNs in cancer by using single-cell RNA-seq, single-cell mass cytometry by time-of-flight (CyTOF), flow cytometry, and functional analysis and suggested that PMN-MDSCs in mice could be identified based on CD14 expression 49. This evidence concerns the gene CD14 and cancer.